Lynparza Maintenance for Ovarian Cancer Takes No Toll on Quality of Life, Study Shows

Lynparza Maintenance for Ovarian Cancer Takes No Toll on Quality of Life, Study Shows
Ovarian cancer patients who responded to platinum-based chemotherapy after failing at least one prior treatment may take Lynparza (olaparib) as maintenance therapy without worrying about their quality of life, a new study shows. The treatment is already approved for preventing disease progression or a relapse, and additional analysis shows that quality of life is not affected. If

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *